These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 23594161

  • 1. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
    Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F.
    J Clin Pharm Ther; 2013 Oct; 38(5):341-9. PubMed ID: 23594161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 Oct; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 8. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS, Pollesello P, Vajda G, Papp Z.
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
    [Abstract] [Full Text] [Related]

  • 9. Levosimendan, a new inotropic and vasodilator agent.
    Toller WG, Stranz C.
    Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
    [Abstract] [Full Text] [Related]

  • 10. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 11. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
    Despas F, Trouillet C, Franchitto N, Labrunee M, Galinier M, Senard JM, Pathak A.
    Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
    [Abstract] [Full Text] [Related]

  • 12. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

  • 13. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 Apr; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan: a novel agent in heart failure.
    Koumallos N, Antoniades C, Tousoulis D, Shirodaria C, Stefanadis C.
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: from basic science to clinical practice.
    Parissis JT, Rafouli-Stergiou P, Paraskevaidis I, Mebazaa A.
    Heart Fail Rev; 2009 Dec; 14(4):265-75. PubMed ID: 19101796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B, Lemm H, Krohe K, Dietz S, Raaz U, Buerke U, Russ M, Schlitt A, Werdan K.
    Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
    Papp Z, Édes I, Fruhwald S, De Hert SG, Salmenperä M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikström BG, Jörgensen K, Filippatos G, Parissis JT, González MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F.
    Int J Cardiol; 2012 Aug 23; 159(2):82-7. PubMed ID: 21784540
    [Abstract] [Full Text] [Related]

  • 20. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
    Lehtonen L.
    Curr Cardiol Rep; 2000 May 23; 2(3):233-43. PubMed ID: 10980898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.